TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
South Korea Sees Limited Impact From New U.S. Tariffs on Advanced AI Chips 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
South Korea Seeks Favorable U.S. Tariff Terms on Memory Chip Imports 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Diagnosing diseases is still a job best done by health professionals, but doctors might just become obsolete in the near future if devices like a newly-developed Breathalyzer keep popping up. By simply breathing into the device, up to 17 types of illnesses can be diagnosed with up to 86 percent accuracy.
Called the “Na-Nose,” the device is basically a nanoarray that’s powered by artificial intelligence. The researchers published the results of their study in ACS Nano detailing how the device can detect everything from certain types of cancer to irritable bowel syndrome.
“We report on an artificially intelligent nanoarray-based on molecularly modified gold nanoparticles and a random network of single-walled carbon nanotubes for noninvasive diagnosis and classification of a number of diseases from exhaled breath,” the paper reads. “The performance of this artificially intelligent nanoarray was clinically assessed on breath samples collected from 1404 subjects having one of 17 different disease conditions included in the study or having no evidence of any disease (healthy controls).”
The researchers also released a video, which explains how the device worked. Hossam Haick from the Technion-Israel Institute of Technology revealed that the whole point of the creation of the device was to catch diseases while the subject is still feeling healthy, Futurism reports.
This is certainly quite a step up in terms of early diagnosis of one of the 17 and hopefully, additional diseases in the future compared to how things are setup now. Most people don’t like going to the doctor for anything, especially male patients who would prefer waiting things out. By providing such people with a way to check if they have an illness without needing to deal with crowded clinics or unnecessary probing, catching serious health issues could become a lot easier.
On that note, such a future is still a long way off since an 86 percent diagnosis accuracy is still too low, USA Today reports. The device would need to be significantly more reliable before it can be used by the public.
